Maternal mental health disorders

Neonatal withdrawal syndrome
Cognitive/neurobehavioural problems
Breastfeeding risksUnstable mental state/risk
Stress on fetus
Poor obstetric outcome
Low birth weight
Intrauterine growth restriction
Poor mother–infant bonding


Severe depression warrants a combination of antidepressant plus CBT and referral to a specialist perinatal psychiatry service if one exists locally. Where risk of suicide or harm to the pregnancy becomes an issue, hospitalization may be needed.





Psychosis in pregnancy



Clinical features


Psychotic symptoms in pregnancy, such as those of schizophrenia and severe bipolar disorder, do not differ from other times in a woman’s life.


Hallucinations in any modality can occur. Most commonly these will be auditory, with the woman complaining of ‘hearing voices’. She may also see things when nothing is there (visual hallucinations) or feel things on her skin (tactile hallucinations).


Delusions (fixed false beliefs) that are held with absolute conviction are the other main psychotic symptom, and persecutory delusions are the most common. Other types of delusions that may be evident include grandiose, nihilistic, jealous, hypochondriacal or bizarre.


In chronic schizophrenia, ‘negative’ symptoms such as affective blunting, poverty of speech (alogia), loss of drive (avolition) and social withdrawal (asociality) may be predominant and disabling.


Bipolar disorder that is unstable presents with hypomania/mania or depression. Hypomania/mania is characterized by elevated mood, overactivity, racing thoughts, grandiose thinking, pressured speech, disinhibition and decreased need for sleep. Depressive symptoms include pervasive low mood, loss of interest and enjoyment (anhedonia), poor concentration, sleep disturbance, negative thinking and hopelessness.



Treatment


Management of pregnant women with psychosis is complex and requires an integrated multidisciplinary approach including psychiatry, obstetrics, paediatrics and social services. The aim is to maximize the mental and physical health of the mother while minimizing any risks to the child. Success hinges on forward planning, joint working and good communication between disciplines.


As a general guide, women with psychosis who become pregnant while on antipsychotic medication will, in the majority of cases, need to continue on it as maintenance therapy. However, it is advisable that the lowest effective dose be used in pregnancy. Abrupt discontinuation of antipsychotic and mood-stabilizing medication (e.g. lithium) should be avoided without discussion with a psychiatrist. Polypharmacy is also best avoided in pregnancy.


As with antidepressant prescribing, any decision to start a new antipsychotic in pregnancy should be made after a full discussion of the risks and benefits of the medication with the pregnant woman. A multidisciplinary pre-birth planning meeting around 30 weeks of gestation is essential in all cases of psychosis and for women at particularly high risk of postpartum psychosis (e.g. women with bipolar disorder).


A prophylactic management plan for prevention of postpartum psychosis needs to be made for all bipolar women, even in cases where the condition has been stable for many years. A recommended strategy is to start such women on a low-dose atypical antipsychotic (e.g. olanzapine) immediately after delivery, and to continue this for at least 3 months into the postnatal period.


General principles of prescribing psychotropic medication in pregnancy are summarized in Table 10.2. Current evidence on the safety profile of psychotropic medication in pregnancy is summarized in Table 10.3.



Table 10.2 Principles of prescribing psychotropic medication in pregnancy



Careful risk–benefit assessment



If mild to moderate severity, use non-pharmacological intervention



Avoid first-trimester exposure if possible



Choose drugs with lower risk profiles for mother/fetus/infant



Start at the lowest effective dose and increase slowly



Avoid abrupt discontinuation of maintenance mood-stabilizing/antipsychotic medication without discussion with psychiatrist



Avoid polypharmacy if possible



Table 10.3 Safety profile of psychotropic medication in pregnancy: current evidence









































Medication Evidence
Antidepressants
Selective serotonin reuptake inhibitors (SSRIs)



  • Fluoxetine



  • Sertraline



  • Citalopram

Can be used in pregnancy. Relative risk of birth defects increased but absolute risk small



  • Paroxetine

Not advised in pregnancy
Tricyclic antidepressants (TCAs)



  • Amitriptyline, imipramine, nortriptyline

No convincing data to suggest teratogenicity
Antipsychotics
Atypical



  • Olanzapine, quetiapine, risperidone

No convincing data to suggest teratogenicity. To be used with caution after discussion with psychiatrists
Typical



  • Trifluperidol, haloperidol

Mood stabilizers



  • Lithium



  • Sodium valproate

Fetal cardiac defects
Fetal neural tube defects
Both to be avoided if possible



Postnatal psychiatric disorders



Postpartum blues



Incidence


Affects 50–80% of women.



Onset


Typically starts on second or third postnatal day.



Clinical features




  • depressed mood



  • tearfulness



  • irritability



  • emotional lability



  • feeling overwhelmed



Prognosis


Transient, self-limiting. Symptoms should start to remit by second week. However, women who experience severe postpartum blues may be up to three times more likely to develop postnatal depression, according to research.



Treatment


No specific treatment other than reassurance and support is required.



Postnatal depression



Incidence


Affects 10–15% of women at any time in the first 6 months following childbirth.



Onset


May have a gradual or sudden onset and is usually apparent within 2 months of childbirth.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jan 31, 2017 | Posted by in GYNECOLOGY | Comments Off on Maternal mental health disorders

Full access? Get Clinical Tree

Get Clinical Tree app for offline access